Dow Up0.35% Nasdaq Down0.02%

Cannabis Science, Inc. (CBIS)

-Other OTC
0.07 Up 0.00(2.80%) 3:59PM EDT
ProfileGet Profile for:
Cannabis Science, Inc.
6946 North Academy Boulevard
Suite B #254
Colorado Springs, CO 80918
United States - Map
Phone: 888-889-0888
Fax: 866-943-5085

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:1

Business Summary 

Cannabis Science, Inc. develops, produces, and commercializes phytocannabinoid-based pharmaceutical products. It develops medicines to treat autism, blood pressure, cancer and cancer side effects, and other illnesses, including general health maintenance. The company is developing CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains; CS-S/BCC-1 for basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, it provides an online video-based medical cannabis education system comprising various courses, such as medical cannabis law, medical marijuana, cooking, horticulture, and bud tending. The company has a license agreement with Apothecary Genetics Investments LLC. to produce various brand formulations for California medical cannabis market. Cannabis Science, Inc. is based in Colorado Springs, Colorado.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Cannabis Science, Inc.

Key Executives 
Dr. Dorothy H. Bray Ph.D., 58
Chief Exec. Officer, Pres, Director and Member of Scientific Advisory Board
Mr. Chad Steven Johnson Esq., 46
Co-Founder, Chief Operating Officer, Gen. Counsel and Director
Mr. Raymond C. Dabney , 49
Co-Founder and Management Consultant
Mr. Robert James Kane , 39
Chief Financial Officer and Director
Dr. Richard Ogden Ph.D., CSCS,
Chief Scientific Officer
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders